To improve the survival of patients with brain tumors, Vidya Chandramohan, PhD, focuses on developing bacterial toxin-based therapies for glioblastoma.

The Changing Landscape of Medical School Admissions

In a daring yet successful experiment back in 1995, Matthias Gromeier, MD, discovered that genetic recombination of poliovirus with a distant relative, human rhinovirus type 2, eliminates the disease-causing capacity of poliovirus. Yet, the modified virus retains the ability to infect and damage cancerous cells, owing to their abnormal “wiring,” and—more importantly—provides powerful immune stimulation by inducing host antiviral defenses.

Duke’s Organ Transplant Program: Out With the Old, In With the New